Showing results (151-160 of 319) with videos related to

Sort By:
Pageof 32
Bioconjugate Chemistry|November 20, 2003
A quantitative analysis and chemical approach for the reduction of nonspecific binding proteins on affinity resinsTsuruki Tamura, Tomohiro Terada, Akito Tanaka
Pharmacology|September 9, 2016
Population Pharmacodynamic Model for Bayesian Prediction of Myelosuppression Profiles Based on Routine Clinical Data after Gemcitabine and Carboplatin TreatmentYugo Chisaki, Tomohiro Terada, Yoshitaka Yano
American Journal of Physiology. Renal Physiology|January 15, 2010
Impact of Cyclin B2 and Cell division cycle 2 on tubular hyperplasia in progressive chronic renal failure ratsKumiko Nishihara, Satohiro Masuda, Shunsaku Nakagawa, et al.
The Annals of Pharmacotherapy|March 11, 2004
Lansoprazole-tacrolimus interaction in Japanese transplant recipient with CYP2C19 polymorphismKazushige Takahashi, Hideyuki Motohashi, Atsushi Yonezawa, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 4, 2003
Enhanced expression of enterocyte P-glycoprotein depresses cyclosporine bioavailability in a recipient of living donor liver transplantationSatohiro Masuda, Maki Goto, Tetsuya Kiuchi, et al.
Pharmacogenetics|July 1, 2004
CYP3A5*1-carrying graft liver reduces the concentration/oral dose ratio of tacrolimus in recipients of living-donor liver transplantationMaki Goto, Satohiro Masuda, Tetsuya Kiuchi, et al.
Drug Metabolism and Pharmacokinetics|September 14, 2010
A transient increase of calcineurin phosphatase activity in living-donor kidney transplant recipients with acute rejectionMasahide Fukudo, Ikuko Yano, Toshiya Katsura, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 7, 2008
Relation between mRNA expression level of multidrug resistance 1/ABCB1 in blood cells and required level of tacrolimus in pediatric living-donor liver transplantationMaki Goto, Satohiro Masuda, Tetsuya Kiuchi, et al.
Drug Metabolism and Pharmacokinetics|May 1, 2008
Interaction between tacrolimus and lansoprazole, but not rabeprazole in living-donor liver transplant patients with defects of CYP2C19 and CYP3A5Keiko Hosohata, Satohiro Masuda, Yasuhiro Ogura, et al.
Clinical Pharmacokinetics|October 9, 2003
Forecasting of blood tacrolimus concentrations based on the Bayesian method in adult patients receiving living-donor liver transplantationMasahide Fukudo, Ikuko Yano, Sachio Fukatsu, et al.
Pageof 32